A Research Study Investigating Nonacog Beta Pegol (N9-GP) for Treatment and Prevention of Bleedings in Chinese People With Haemophilia B
NCT05365217
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
30
Enrollment
INDUSTRY
Sponsor class
Conditions
Haemophilia B
Interventions
DRUG:
Nonacog beta pegol
Sponsor
Novo Nordisk A/S